Description
Developer of novel peptide-based therapies intended to address unmet medical needs of psychiatric conditions within the spectrum of depressive and anxiety disorders. The company's therapy helps to identify an unknown family of peptides with biological activity in anxiety and depression, by means of proprietary processing of whey and casein from bovine's milk, enabling baby food manufacturers to reduces the risk of motor mental retardation through their food product.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 01-Apr-2012 | Completed | Generating Revenue |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2020239245-A1 | Synthetic neuromodulatory peptides | Pending | 14-Mar-2019 | 0000000000 | |
CA-3133242-A1 | Synthetic neuromodulatory peptides | Pending | 14-Mar-2019 | 0000000000 |
Name | Representing | Role | Since |
---|---|---|---|
Gennady Babkin | Lactocore | Co-Founder & Chairman | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
MSU Business Incubator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |